Tenaya Therapeutics to Participate at the 35th Annual Piper Sandler Healthcare Conference

Rhea-AI Summary

Tenaya Therapeutics, Inc. (TNYA) CEO Faraz Ali to participate in 35th Annual Piper Sandler Healthcare Conference. Webcast available on company's website.

SOUTH SAN FRANCISCO, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that Faraz Ali, Chief Executive Officer, will participate in the 35^th Annual Piper Sandler Healthcare Conference taking place in New York, NY.

Details of participation are as follows:

Fireside Chat
Date: November 28, 2023
Time: 6:30 AM PT / 9:30 AM ET

A webcast of the Piper Sandler event will be available by visiting the Investors section of Tenaya’s website. A replay of the webcast will be available on the Tenaya website for approximately 30 days following the conference.

About Tenaya Therapeutics
Tenaya Therapeutics is a clinical-stage biotechnology company committed to a bold mission: to discover, develop and deliver potentially curative therapies that address the underlying drivers of heart disease. Leveraging its integrated and interrelated Gene Therapy, Cellular Regeneration and Precision Medicine platforms and proprietary core capabilities, the company is advancing a pipeline of novel therapies with diverse treatment modalities for rare genetic cardiovascular disorders and more prevalent heart conditions. Tenaya’s most advanced candidates include TN-201, a gene therapy for MYBPC3-associated hypertrophic cardiomyopathy (HCM), TN-401, a gene therapy for PKP2-associated arrhythmogenic right ventricular cardiomyopathy (ARVC), and TN-301, a small molecule HDAC6 inhibitor being initially developed for heart failure with preserved ejection fraction (HFpEF). Tenaya also has multiple early-stage programs progressing through preclinical development. For more information, visit www.tenayatherapeutics.com.

Contacts
Michelle Corral
VP, Corporate Communications and Investor Relations
IR@tenayathera.com

Investors
Julie Seidel
Stern Investor Relations
Julie.seidel@SternIR.com

FAQ

When is the 35th Annual Piper Sandler Healthcare Conference?

The conference is scheduled for November 28, 2023.

What time will Tenaya Therapeutics CEO participate in the Fireside Chat?

The CEO will participate at 6:30 AM PT / 9:30 AM ET.

Where can I access the webcast of the Piper Sandler event?

The webcast will be available on Tenaya's website in the Investors section.

How long will the webcast be available for replay?

The webcast will be available for approximately 30 days following the conference on the Tenaya website.